At a glance
- Originator Takeda
- Developer Novartis
- Class Antiarrhythmics; Vasodilators
- Mechanism of Action Adenosine A2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Ischaemic heart disorders